Yoichiro Kato

1.6k total citations
54 papers, 449 citations indexed

About

Yoichiro Kato is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yoichiro Kato has authored 54 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 20 papers in Oncology. Recurrent topics in Yoichiro Kato's work include Bladder and Urothelial Cancer Treatments (16 papers), Renal cell carcinoma treatment (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Yoichiro Kato is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Renal cell carcinoma treatment (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Yoichiro Kato collaborates with scholars based in Japan and United States. Yoichiro Kato's co-authors include Wataru Obara, Ryo Takata, Renpei Kato, Mitsugu Kanehira, Tomoaki Fujioka, Tamotsu Sugai, Daiki Ikarashi, Shigekatsu Maekawa, Toyomasa Katagiri and Yusuke Nakamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Urology.

In The Last Decade

Yoichiro Kato

50 papers receiving 446 citations

Peers

Yoichiro Kato
Güneş Güner United States
Rupesh I. Bhatt United Kingdom
Dennis Peters Netherlands
Hu Li China
Dominic W. Lai United States
Yoichiro Kato
Citations per year, relative to Yoichiro Kato Yoichiro Kato (= 1×) peers Renpei Kato

Countries citing papers authored by Yoichiro Kato

Since Specialization
Citations

This map shows the geographic impact of Yoichiro Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Kato more than expected).

Fields of papers citing papers by Yoichiro Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Kato. The network helps show where Yoichiro Kato may publish in the future.

Co-authorship network of co-authors of Yoichiro Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichiro Kato. A scholar is included among the top collaborators of Yoichiro Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichiro Kato. Yoichiro Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Yoichiro, et al.. (2024). Emphysematous pyelonephritis diagnosed by acute changes detected via computed tomography: A case report. SHILAP Revista de lepidopterología. 12(8). e9211–e9211.
2.
Ikarashi, Daiki, Shigehisa Kitano, Makiko Yamashita, et al.. (2024). Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer. Scientific Reports. 14(1). 1442–1442. 1 indexed citations
3.
Abé, Masakazu, Noriyuki Sasaki, Akiko Yashima‐Abo, et al.. (2023). Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Science. 115(2). 529–539. 11 indexed citations
4.
Kato, Yoichiro, Renpei Kato, Shigekatsu Maekawa, et al.. (2022). 後腹膜に発生した気管支原性嚢胞. Kyoto University Research Information Repository (Kyoto University). 1 indexed citations
5.
Kato, Renpei, Shigekatsu Maekawa, Yoichiro Kato, et al.. (2022). A case of male perineal aggressive angiomyxoma with expressions of female hormone receptors. IJU Case Reports. 5(4). 308–311. 1 indexed citations
6.
Kato, Renpei, Shigekatsu Maekawa, Yoichiro Kato, et al.. (2022). Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitors. International Immunopharmacology. 113(Pt B). 109443–109443. 2 indexed citations
7.
Takata, Ryo, Mitsugu Kanehira, Yoichiro Kato, et al.. (2021). Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study. BMC Medical Education. 21(1). 498–498. 8 indexed citations
8.
Ikarashi, Daiki, Shigehisa Kitano, Takayuki Nakayama, et al.. (2021). Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting. British Journal of Cancer. 126(4). 606–614. 17 indexed citations
9.
Kato, Renpei, Hiroaki Itamochi, Shigekatsu Maekawa, et al.. (2020). Rapid progression of recurrent disease in a patient with renal cell carcinoma with vaginal metastasis. SHILAP Revista de lepidopterología. 3(5). 185–188. 5 indexed citations
10.
Kato, Renpei, Daiki Ikarashi, Shigekatsu Maekawa, et al.. (2020). Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting. Translational Oncology. 13(6). 100771–100771. 4 indexed citations
11.
Abé, Masakazu, Daiki Ikarashi, Renpei Kato, et al.. (2020). Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice. International Journal of Clinical Oncology. 25(5). 899–905. 37 indexed citations
12.
Ikarashi, Daiki, Yoichiro Kato, Mitsugu Kanehira, et al.. (2018). Appropriate preoperative membranous urethral length predicts recovery of urinary continence after robot-assisted laparoscopic prostatectomy. World Journal of Surgical Oncology. 16(1). 224–224. 21 indexed citations
13.
Kato, Renpei, et al.. (2017). Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma. BMC Cancer. 17(1). 214–214. 8 indexed citations
14.
Kato, Yoichiro, Shuhei Ishii, Masamichi Suzuki, et al.. (2017). Renal pelvic cancer with spleen invasion arising in horseshoe kidney; a case report. Urology Case Reports. 16. 123–125. 1 indexed citations
15.
Ikarashi, Daiki, Kazuyuki Ishida, Masahiro Kashiwaba, et al.. (2017). Sporadic breast metastasis derived from renal cell carcinoma: A case report. Urology Case Reports. 16. 126–128. 2 indexed citations
16.
Ikarashi, Daiki, Renpei Kato, Yoichiro Kato, et al.. (2017). Efficacy of Everolimus for Treating Renal Angiomyolipoma with Inferior Vena Cava Thrombus Associated with Tuberous Sclerosis: A Case Report. Urology Case Reports. 11. 11–13. 7 indexed citations
17.
Obara, Wataru, Takashi Karashima, Kazuyoshi Takeda, et al.. (2016). Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy. 66(1). 17–24. 16 indexed citations
19.
Iwasaki, Kiyotaka, Wataru Obara, Yoichiro Kato, et al.. (2012). Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer. Japanese Journal of Clinical Oncology. 43(2). 193–199. 12 indexed citations
20.
Kato, Yoichiro, et al.. (2008). Primary mucosa‐associated lymphoid tissue‐type lymphoma arising in the kidney. International Journal of Urology. 15(1). 90–92. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026